Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 24, 2026
Blackstone Inc. (BX) Reports Robust Q2 Earnings with Distributable Earnings Rising +26%

Blackstone Inc. (BX) Reports Robust Q2 Earnings with Distributable Earnings Rising +26%

Key Takeaways

  • Distributable earnings climbed 26% year-over-year to $2.0 billion, or $1.52 per share, surpassing the consensus analyst estimate of approximately $1.34.
  • Total assets under management (AUM) reached a record $1.35 trillion, fueled by nearly $70 billion in quarterly inflows and an 11% increase from the prior year.
  • Fee-related earnings (FRE) rose 22% year-over-year to $1.8 billion, reflecting sustained momentum across management fees and fee-related performance revenues.
  • AI-linked investments drove standout performance, with nine of Blackstone's ten best-appreciating assets tied to artificial intelligence infrastructure, data centers, and energy.
  • Stock reaction was muted, with shares closing down 0.72% at $121.94, as broader private credit concerns and geopolitical uncertainty weighed on investor sentiment.
  • A quarterly dividend of $1.29 per share was declared, bringing trailing twelve-month dividends to $5.23 per share.

Why Blackstone's Results Matter Right Now

Blackstone Inc. (NYSE: BX), the world's largest alternative asset manager, serves as a key indicator for the broader alternative investment space. Its second-quarter figures offer meaningful insight into how institutional and retail investors are directing capital across private equity, real estate, credit, and infrastructure in the current environment. Ahead of the release, attention centered on whether the artificial intelligence trend was producing measurable earnings growth for alternative managers and how private credit strategies were handling redemption activity. With nearly $1.35 trillion in AUM across major alternative categories, these numbers provide a useful gauge of institutional demand, fundraising conditions, and the pace of realizations in global private markets.

Breaking Down the Reported Figures

Blackstone posted a solid second quarter that topped expectations on both revenue and earnings lines. Distributable earnings, an important gauge for these managers as it shows cash available for distributions, came in at $2.0 billion, or $1.52 per common share. That marked a 26% increase from the $1.21 per share posted a year earlier and cleared the consensus estimate of roughly $1.34 to $1.35 per share.

Total segment revenues reached $3.80 billion, above the consensus of about $3.46 billion. GAAP revenues rose sharply to $5.04 billion, well ahead of the $3.38 billion consensus, driven by performance allocations. GAAP net income attributable to Blackstone was $1.2 billion, or $1.54 per share on a basic and diluted basis.

Fee-related earnings, which focus on the more stable management fee component, advanced 22% year-over-year to $1.8 billion, or $1.43 per share. Management and advisory fees, net, grew 11% to $2.25 billion, while fee-related performance revenues increased 68% to $793 million. Net realizations rose 27% to $414 million, helped by asset sales including data center positions and energy exits. Net accrued performance revenue reached $7.5 billion, or $6.00 per share, the highest level in four years.

Market Reaction and Investor Sentiment

Even with the earnings beat, Blackstone shares fell 0.72% on July 23 to close at $121.94, well below the 52-week high of $190.09. The measured response highlights the contrast between strong operating results and ongoing macro concerns. Redemption requests on the flagship private credit fund BCRED reached about 10% of net asset value in the quarter, while geopolitical factors have tempered near-term exits. The stock had already dropped roughly 35% from its 52-week high before the report, so some caution was likely reflected in the price. The results affirmed Blackstone's AI-focused approach, yet sentiment around private credit and realization timing continues to influence the reaction.

Forward Outlook and Areas to Watch

Management presented a constructive view supported by several growth drivers. CFO Michael Chae noted expectations for base management fee growth to return to double digits in 2027, backed by private equity drawdowns, expansion of perpetual capital vehicles, continued credit deployment, and steadier real estate fee trends. The AI focus stays central, with Blackstone positioned as a major private capital provider in the ecosystem through data centers, energy infrastructure, and investments such as Anthropic. The data center platform now totals roughly $185 billion in value and could double in coming years with successful execution. Partnerships with Google on AI cloud infrastructure and Broadcom on large-scale AI compute financing illustrate the scope of the effort.

Net realizations may ease sequentially in the third quarter but are expected to strengthen in the fourth quarter and into 2027, partly supported by a more active IPO market. U.S. IPO activity reportedly increased sixfold in the first half of 2026 versus the prior year, and Blackstone has eight IPOs on file globally. Early third-quarter redemption requests for BCRED have declined materially. Investors will want to track redemption trends, real estate return trajectories relative to public REITs, and whether the AI investment cycle maintains momentum without signs of excess.

Using Data-Driven Tools to Compare Opportunities

After reviewing the results, I checked this using Tickeron's AI Screener to see how Blackstone compares to peers in the alternative asset manager space. The tool lets users apply filters across industry groups, market caps, technical signals, volatility measures, and AI-driven indicators to surface relevant names more efficiently. It supports both shorter-term trading ideas and longer-term positioning by highlighting patterns and breakout candidates based on defined criteria. This kind of screening can help refine ideas around financial services and alternative managers following earnings season.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BX

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for BX turns positive, indicating new upward trend

BX saw its Momentum Indicator move above the 0 level on July 31, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned positive. In of the 77 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

BX moved above its 50-day moving average on July 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BX crossed bullishly above the 50-day moving average on July 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BX advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 240 cases where BX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BX broke above its upper Bollinger Band on August 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BX's P/B Ratio (12.195) is slightly higher than the industry average of (3.569). P/E Ratio (32.754) is within average values for comparable stocks, (27.541). Projected Growth (PEG Ratio) (1.726) is also within normal values, averaging (1.269). Dividend Yield (0.036) settles around the average of (0.086) among similar stocks. P/S Ratio (8.475) is also within normal values, averaging (17.979).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 9.98B. The market cap for tickers in the group ranges from 57 to 179.79B. BLK holds the highest valuation in this group at 179.79B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 3%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 2%. CWD experienced the highest price growth at 46%, while BENF experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 78% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 57
Price Growth Rating: 54
SMR Rating: 74
Profit Risk Rating: 77
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
BX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of investment and fund management services

Industry InvestmentManagers

Profile
Details
Industry
Investment Managers
Address
345 Park Avenue
Phone
+1 212 583-5000
Employees
4735
Web
https://www.blackstone.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.